<DOC>
	<DOCNO>NCT00254566</DOCNO>
	<brief_summary>This trial research drug study compare effect two antibiotic treatment acute exacerbation chronic bronchitis</brief_summary>
	<brief_title>A Trial To Evaluate Two Antibiotics For The Treatment Of Acute Exacerbation Of Chronic Bronchitis ( AECB )</brief_title>
	<detailed_description />
	<mesh_term>Bronchitis</mesh_term>
	<mesh_term>Acute Disease</mesh_term>
	<mesh_term>Bronchitis , Chronic</mesh_term>
	<mesh_term>Moxifloxacin</mesh_term>
	<mesh_term>Fluoroquinolones</mesh_term>
	<mesh_term>Norgestimate , ethinyl estradiol drug combination</mesh_term>
	<criteria>Diagnosis chronic bronchitis ( chronic cough sputum production day three consecutive month two consecutive year ) clinical evidence AECB demonstrate follow symptom : Production purulent sputum define Gram stain sputum specimen Presence follow : Increased sputum production Increased dyspnea Increased cough At least two exacerbation AECB past 12 month Documented FEV1 le 80 % predict A chest radiograph consistent pneumonia Treatment systemic antibiotic within twentyone day prior study entry chance receive systemic antibiotic study participation</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2009</verification_date>
	<keyword>Azithromycin SR ; Moxifloxacin ; Acute exacerbation chronic bronchitis ( AECB )</keyword>
</DOC>